1）Designs and implements biochemical and cellular assays to guide the target validation primarily in the areas of oncology, immunology and neurosciences;
2）Leads the design and implementation of screening strategies for Hit Identification through either High Throughput Screening or other technologies;
3）Provides leadership in developing innovative approaches to screening and hit triage;
4）Ensures hits are pharmacologically relevant by applying necessary validation assays;
5）Analyzes validation and screening data including presentation at program team meetings;
6）Works with other leaders in non-clinical R&D to design mechanisms of action studies for drug candidates;
7）Responsible for grow internal talents and capabilities through recruiting and mentoring
1）PhD in biochemistry, biophysics, cell biology, pharmacology or related areas with a minimal of 8 years of industry experience;
2）Strong expertise in in vitro profiling and pharmacology using biochemical, biophysical, and cell based methods in at least one of the three therapeutic areas: oncology, immunology and neurosciences.;
3）Record of success in assay development for Hit Identification using biochemical and cellular methods;
4）Demonstrated experience and expertise with Hit triage;
5）In-depth knowledge of entire drug discovery process;
6）Good communication skills and experience of working external collaborators.
一家极具创新力的大型制药集团，产品覆盖：抗肿瘤，风湿免疫，中枢神经，心血管，抗感染等领域；目前在研项目30多个近10个创新药项目。该集团研发中心管理层拥有多年巨头管理工作经验。
